Integrative Analyses of Mendelian Randomization and Bioinformatics Reveal Casual Relationship and Genetic Links Between COVID-19 and Knee Osteoarthritis

Overview

Journal BMC Med Genomics

Publisher Biomed Central

Specialty Genetics

Date 2025 Jan 3

PMID 39748395

Authors

Xiao Zheng

Jinhao Li

Qinfeng Ma

Jianping Gong

Jianbo Pan

Affiliations

Soon will be listed here.

Abstract

Background: Clinical and epidemiological analyses have found an association between coronavirus disease 2019 (COVID-19) and knee osteoarthritis (KOA). Infection with COVID-19 may increase the risk of developing KOA.

Objectives: This study aimed to investigate the potential causal relationship between COVID-19 and KOA using Mendelian randomization (MR) and to explore the underlying mechanisms through a systematic bioinformatics approach.

Methods: Our investigation focused on exploring the potential causal relationship between COVID-19, acute upper respiratory tract infection (URTI) and KOA utilizing a bidirectional MR approach. Additionally, we conducted differential gene expression analysis using public datasets related to these three conditions. Subsequent analyses, including transcriptional regulation analysis, immune cell infiltration analysis, single-cell analysis, and druggability evaluation, were performed to explore potential mechanisms and prioritize therapeutic targets.

Results: The results indicate that COVID-19 has a one-way impact on KOA, while URTI does not play a causal role in this association. Ribosomal dysfunction may serve as an intermediate factor connecting COVID-19 with KOA. Specifically, COVID-19 has the potential to influence the metabolic processes of the extracellular matrix, potentially impacting the joint homeostasis. A specific group of genes (COL10A1, BGN, COL3A1, COMP, ACAN, THBS2, COL5A1, COL16A1, COL5A2) has been identified as a shared transcriptomic signature in response to KOA with COVID-19. Imatinib, Adiponectin, Myricetin, Tranexamic acid, and Chenodeoxycholic acid are potential drugs for the treatment of KOA patients with COVID-19.

Conclusions: This study uniquely combines Mendelian randomization and bioinformatics tools to explore the possibility of a causal relationship and genetic association between COVID-19 and KOA. These findings are expected to provide novel perspectives on the underlying biological mechanisms that link COVID-19 and KOA.

References

Willard K, Mannion S, Saunders C, Collins M, September A . The interaction of polymorphisms in extracellular matrix genes and underlying miRNA motifs that modulate susceptibility to anterior cruciate ligament rupture. J Sci Med Sport. 2017; 21(1):22-28. DOI: 10.1016/j.jsams.2017.08.017. View

Traupe H, van den Ouweland A, van Oost B, Vogel W, Vetter U, Warren S . Fine mapping of the human biglycan (BGN) gene within the Xq28 region employing a hybrid cell panel. Genomics. 1992; 13(2):481-3. DOI: 10.1016/0888-7543(92)90279-2. View

Jablonska-Trypuc A, Matejczyk M, Rosochacki S . Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs. J Enzyme Inhib Med Chem. 2016; 31(sup1):177-183. DOI: 10.3109/14756366.2016.1161620. View

Mehta P, McAuley D, Brown M, Sanchez E, Tattersall R, Manson J . COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020; 395(10229):1033-1034. PMC: 7270045. DOI: 10.1016/S0140-6736(20)30628-0. View

Han Y, Li X, Yan M, Yang M, Wang S, Pan J . Oxidative damage induces apoptosis and promotes calcification in disc cartilage endplate cell through ROS/MAPK/NF-κB pathway: Implications for disc degeneration. Biochem Biophys Res Commun. 2017; 516(3):1026-1032. DOI: 10.1016/j.bbrc.2017.03.111. View

Bhosale A, Richardson J . Articular cartilage: structure, injuries and review of management. Br Med Bull. 2008; 87:77-95. DOI: 10.1093/bmb/ldn025. View

Deng Z, Li Y, Gao X, Lei G, Huard J . Bone morphogenetic proteins for articular cartilage regeneration. Osteoarthritis Cartilage. 2018; 26(9):1153-1161. DOI: 10.1016/j.joca.2018.03.007. View

Lee J, Hyeon D, Hwang D . Single-cell multiomics: technologies and data analysis methods. Exp Mol Med. 2020; 52(9):1428-1442. PMC: 8080692. DOI: 10.1038/s12276-020-0420-2. View

Chao P, Lee L . [Impact of the COVID-19 Pandemic on Health-Related Quality of Life in Older Adults With Preoperative Knee Osteoarthritis]. Hu Li Za Zhi. 2023; 70(3):26-36. DOI: 10.6224/JN.202306_70(3).05. View

10.

Pelletier J, Martel-Pelletier J, Rannou F, Cooper C . Efficacy and safety of oral NSAIDs and analgesics in the management of osteoarthritis: Evidence from real-life setting trials and surveys. Semin Arthritis Rheum. 2016; 45(4 Suppl):S22-7. DOI: 10.1016/j.semarthrit.2015.11.009. View

11.

Vignon E, Mathieu P, Bejui J, Descotes J, Hartmann D, Patricot L . Study of an inhibitor of plasminogen activator (tranexamic acid) in the treatment of experimental osteoarthritis. J Rheumatol Suppl. 1991; 27:131-3. View

12.

Hanna J, Hossain G, Kocerha J . The Potential for microRNA Therapeutics and Clinical Research. Front Genet. 2019; 10:478. PMC: 6532434. DOI: 10.3389/fgene.2019.00478. View

13.

Mak K, Png C, Lee D . Type V Collagen in Health, Disease, and Fibrosis. Anat Rec (Hoboken). 2016; 299(5):613-29. DOI: 10.1002/ar.23330. View

14.

Colombi M, Dordoni C, Venturini M, Ciaccio C, Morlino S, Chiarelli N . Spectrum of mucocutaneous, ocular and facial features and delineation of novel presentations in 62 classical Ehlers-Danlos syndrome patients. Clin Genet. 2017; 92(6):624-631. DOI: 10.1111/cge.13052. View

15.

Grassel S, Bauer R . Collagen XVI in health and disease. Matrix Biol. 2012; 32(2):64-73. DOI: 10.1016/j.matbio.2012.11.001. View

16.

Sun K, Luo J, Guo J, Yao X, Jing X, Guo F . The PI3K/AKT/mTOR signaling pathway in osteoarthritis: a narrative review. Osteoarthritis Cartilage. 2020; 28(4):400-409. DOI: 10.1016/j.joca.2020.02.027. View

17.

van den Akker G, Caron M, Peffers M, Welting T . Ribosome dysfunction in osteoarthritis. Curr Opin Rheumatol. 2021; 34(1):61-67. PMC: 8638817. DOI: 10.1097/BOR.0000000000000858. View

18.

Lauwers M, Au M, Yuan S, Wen C . COVID-19 in Joint Ageing and Osteoarthritis: Current Status and Perspectives. Int J Mol Sci. 2022; 23(2). PMC: 8775477. DOI: 10.3390/ijms23020720. View

19.

Zheng H, Shi Y, Liang J, Lu L, Chen M . Modifiable factors for migraine prophylaxis: A mendelian randomization analysis. Front Pharmacol. 2023; 14:1010996. PMC: 9878312. DOI: 10.3389/fphar.2023.1010996. View

20.

Zhu N, Zhang D, Wang W, Li X, Yang B, Song J . A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020; 382(8):727-733. PMC: 7092803. DOI: 10.1056/NEJMoa2001017. View